Implantica AG (IMP-A-SDB.ST)
SEK 37.65
(2.45%)
SEK 37.65
(2.45%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -87.33 Million EUR | 19.52% |
| 2022 | -108.13 Million EUR | -28.22% |
| 2021 | -84.33 Million EUR | 13.44% |
| 2020 | -97.42 Million EUR | -4583.43% |
| 2019 | 2.17 Million EUR | 1739.75% |
| 2018 | 118.11 Thousand EUR | 202.93% |
| 2017 | -114.75 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -79.59 Million EUR | 8.86% |
| 2024 Q2 | -74.02 Million EUR | 7.9% |
| 2023 Q1 | -101.59 Million EUR | 6.05% |
| 2023 Q3 | -93.19 Million EUR | 4.41% |
| 2023 FY | -87.33 Million EUR | 19.23% |
| 2023 Q4 | -87.33 Million EUR | 6.28% |
| 2023 Q2 | -97.49 Million EUR | 4.03% |
| 2022 Q1 | -76.96 Million EUR | 8.74% |
| 2022 Q2 | -71.33 Million EUR | 7.32% |
| 2022 Q3 | -66.07 Million EUR | 7.36% |
| 2022 Q4 | -108.13 Million EUR | -63.65% |
| 2022 FY | -108.13 Million EUR | -28.22% |
| 2021 Q3 | -89.32 Million EUR | 39.34% |
| 2021 Q1 | -93.23 Million EUR | 4.3% |
| 2021 Q2 | -147.25 Million EUR | -57.94% |
| 2021 FY | -84.33 Million EUR | 13.44% |
| 2021 Q4 | -84.33 Million EUR | 5.59% |
| 2020 Q1 | 34 Thousand EUR | -98.44% |
| 2020 Q3 | -90.5 Million EUR | -1339.37% |
| 2020 Q2 | 7.3 Million EUR | 21378.33% |
| 2020 FY | -97.42 Million EUR | -4583.43% |
| 2020 Q4 | -97.42 Million EUR | -7.64% |
| 2019 FY | 2.17 Million EUR | 1739.75% |
| 2019 Q4 | 2.17 Million EUR | 0.0% |
| 2018 FY | 118.11 Thousand EUR | 202.93% |
| 2017 FY | -114.75 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | -148.479% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 107.119% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 107.119% |
| Arcoma AB | -1.12 Million SEK | -7642.73% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | 179.483% |
| BICO Group AB (publ) | 927.9 Million SEK | 109.412% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | 167.809% |
| CellaVision AB (publ) | -56.94 Million SEK | -53.381% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | -487.067% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | -932.949% |
| C-Rad AB (publ) | -127.6 Million SEK | 31.553% |
| Duearity AB (publ) | 10.23 Million SEK | 953.66% |
| Dignitana AB (publ) | 13.07 Million SEK | 767.875% |
| Episurf Medical AB (publ) | -52.7 Million SEK | -65.727% |
| Getinge AB (publ) | 5.4 Billion SEK | 101.615% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | -149.159% |
| Iconovo AB (publ) | -10.75 Million SEK | -712.044% |
| Integrum AB (publ) | -10.47 Million SEK | -733.653% |
| Luxbright AB (publ) | -13.83 Million SEK | -531.353% |
| Mentice AB (publ) | -49.56 Million SEK | -76.213% |
| OssDsign AB (publ) | -162.78 Million SEK | 46.349% |
| Paxman AB (publ) | -11.41 Million SEK | -665.384% |
| Promimic AB (publ) | -50.32 Million SEK | -73.555% |
| Qlife Holding AB (publ) | 19.07 Million SEK | 557.986% |
| SciBase Holding AB (publ) | -27.32 Million SEK | -219.638% |
| ScandiDos AB (publ) | -1.53 Million SEK | -5604.637% |
| Sectra AB (publ) | -772.85 Million SEK | 88.699% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 61.504% |
| Senzime AB (publ) | -139.54 Million SEK | 37.411% |
| SpectraCure AB (publ) | -50.23 Million SEK | -73.862% |
| Stille AB | -178.5 Million SEK | 51.072% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 107.112% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 59.312% |